FCM analysis indicated that the blasts exhibited an immunophenotype consistent with acute myeloid leukemia (AML), showing positivity for CD11c, CD33, CD64, and HLA-DR, while being negative for CD10, CD19, and CD20 (Figure 1F). This evidence concerns the gene CD19 and acute myeloid leukemia.